Articles

• Needed: New market access models in Ireland

  In Ireland, an asthma management pilot suggests pharmaceutical companies need to start thinking more creatively about market access.

  (Nov 26, 2009)
• Better management means better market access

  How to create unified market access strategies by fostering inter-departmental collaboration

  (Dec 14, 2009)
• Gaining market access by providing value for money

  Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report.

  (Jan 28, 2010)
• HTAs go global: What it means for market access
  (Jan 28, 2010)
• How pharmacists can help improve patient compliance

  Peter Mansell reports on the changing role of pharmacists in promoting adherence.

  (Feb 9, 2010)
• Health economics data and market access

  Peter Mansell reports on how pharmacoeconomics can help define data requirements to match market access plans.

  (Feb 25, 2010)
• The internet as a compliance and health management tool

  Peter Mansell investigates how pharma companies can use Web-based media to improve adherence and become part of the treatment decision-making process.

  (Apr 6, 2010)
• Different forecasting methods in the US and Europe

  Peter Mansell talks to Kevin Norell, senior vice president of advanced methods at Kantar Health, about the need to stay flexible with market forecasts.

  (Apr 13, 2010)
• Health data and comparative effectiveness

  Peter Mansell explains why the pharma industry needs to reclaim data ownership in ways that promote both transparency and market opportunity.

  (Apr 19, 2010)
• Pharma 3.0: what it means for market access

  Peter Mansell explores the new partnerships and new models needed to assure successful market access strategies.

  (Apr 20, 2010)
• 1
• 2
• 3
• 4
• Next
• Last

History

Member for

2 years 10 weeks